Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
A high-definition TV promises a superior visual experience. To fulfill this promise, the TV must be properly connected to a cable or satellite receiver. Otherwise, no image will appear.
In a similar way, the eye cells that initiate vision – known as photoreceptors – must make the right connections within the eye for a person to see. However, the mechanisms that control the maturation of photoreceptors and their ability to form these connections are unclear.
Dr. Valerie Wallace and her team have developed an efficient and inexpensive method to identify and study these mechanisms.
The researchers isolated eye cells from an experimental model and then seeded the cells in a dish. They then assessed the effect of adding or removing different factors – such as genes or proteins – on the ability of photoreceptors to establish connections with the other cells in the dish.
This method could help researchers develop new treatments for vision loss, such as cell replacement therapy. This emerging therapy involves the surgical transplantation of healthy photoreceptors from a donor into a host, replacing the lost or dysfunctional photoreceptors.
To date, all attempts to restore vision using cell replacement therapy have failed because the transplanted photoreceptors do not establish functional connections with host cells.
"Our method could reveal factors that promote the connections needed for cell replacement therapy to succeed," states Dr. Wallace.
The Power of Team Work
Research projects often require diverse expertise and experience, combined with long hours of careful work. Many different people contribute, including researchers, trainees, technicians and other support staff. This was certainly the case for Dr. Wallace's study.
While Dr. Wallace supervised the research, several of her trainees and staff developed and tested the method.
Samuel Tsai, the first author of the study, performed the majority of the work, which formed the basis of his Master's thesis.
Other trainees who made important contributions include postdoctoral fellow Dr. Arturo Ortin-Martinez and graduate students Akshay Gurdita and Nicole Yan.
Supported by Brain Canada, the Foundation Fighting Blindness, the Ontario Institute for Regenerative Medicine, the Krembil Foundation, the Canada First Research Excellence Fund and the Toronto General & Western Hospital Foundation. MS Shoichet holds a Tier I Canada Research Chair (CRC) in Tissue Engineering. VA Wallace holds a Tier I CRC in Retina Regeneration.